×
S&P 500   3,809.26 (-0.32%)
DOW   30,966.26 (+0.06%)
QQQ   282.11 (-0.50%)
AAPL   138.83 (+1.01%)
MSFT   258.90 (+0.94%)
META   162.63 (+1.21%)
GOOGL   2,222.43 (-0.79%)
AMZN   108.48 (+1.01%)
TSLA   668.01 (-4.30%)
NVDA   153.27 (-4.10%)
NIO   21.50 (-3.85%)
BABA   115.21 (-1.33%)
AMD   76.61 (-5.16%)
MU   55.41 (-4.23%)
CGC   3.51 (-2.77%)
T   20.80 (+0.92%)
GE   63.70 (-3.31%)
F   11.44 (-3.13%)
DIS   95.02 (-0.94%)
AMC   13.45 (+0.52%)
PFE   50.82 (+0.32%)
PYPL   70.87 (-1.32%)
NFLX   175.71 (-2.17%)
S&P 500   3,809.26 (-0.32%)
DOW   30,966.26 (+0.06%)
QQQ   282.11 (-0.50%)
AAPL   138.83 (+1.01%)
MSFT   258.90 (+0.94%)
META   162.63 (+1.21%)
GOOGL   2,222.43 (-0.79%)
AMZN   108.48 (+1.01%)
TSLA   668.01 (-4.30%)
NVDA   153.27 (-4.10%)
NIO   21.50 (-3.85%)
BABA   115.21 (-1.33%)
AMD   76.61 (-5.16%)
MU   55.41 (-4.23%)
CGC   3.51 (-2.77%)
T   20.80 (+0.92%)
GE   63.70 (-3.31%)
F   11.44 (-3.13%)
DIS   95.02 (-0.94%)
AMC   13.45 (+0.52%)
PFE   50.82 (+0.32%)
PYPL   70.87 (-1.32%)
NFLX   175.71 (-2.17%)
S&P 500   3,809.26 (-0.32%)
DOW   30,966.26 (+0.06%)
QQQ   282.11 (-0.50%)
AAPL   138.83 (+1.01%)
MSFT   258.90 (+0.94%)
META   162.63 (+1.21%)
GOOGL   2,222.43 (-0.79%)
AMZN   108.48 (+1.01%)
TSLA   668.01 (-4.30%)
NVDA   153.27 (-4.10%)
NIO   21.50 (-3.85%)
BABA   115.21 (-1.33%)
AMD   76.61 (-5.16%)
MU   55.41 (-4.23%)
CGC   3.51 (-2.77%)
T   20.80 (+0.92%)
GE   63.70 (-3.31%)
F   11.44 (-3.13%)
DIS   95.02 (-0.94%)
AMC   13.45 (+0.52%)
PFE   50.82 (+0.32%)
PYPL   70.87 (-1.32%)
NFLX   175.71 (-2.17%)
S&P 500   3,809.26 (-0.32%)
DOW   30,966.26 (+0.06%)
QQQ   282.11 (-0.50%)
AAPL   138.83 (+1.01%)
MSFT   258.90 (+0.94%)
META   162.63 (+1.21%)
GOOGL   2,222.43 (-0.79%)
AMZN   108.48 (+1.01%)
TSLA   668.01 (-4.30%)
NVDA   153.27 (-4.10%)
NIO   21.50 (-3.85%)
BABA   115.21 (-1.33%)
AMD   76.61 (-5.16%)
MU   55.41 (-4.23%)
CGC   3.51 (-2.77%)
T   20.80 (+0.92%)
GE   63.70 (-3.31%)
F   11.44 (-3.13%)
DIS   95.02 (-0.94%)
AMC   13.45 (+0.52%)
PFE   50.82 (+0.32%)
PYPL   70.87 (-1.32%)
NFLX   175.71 (-2.17%)
OTCMKTS:CNVVY

ConvaTec Group Stock Forecast, Price & News

$11.20
+0.22 (+2.00%)
(As of 06/28/2022 10:14 AM ET)
Add
Compare
Today's Range
$11.19
$11.20
50-Day Range
$9.97
$11.52
52-Week Range
$9.06
$14.71
Volume
4,200 shs
Average Volume
1,353 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive CNVVY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter.

CNVVY Stock Forecast (MarketRank)

Overall MarketRank

0.67 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
ConvaTec Group logo

About ConvaTec Group (OTCMKTS:CNVVY)

ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as from traumatic injury, burns, invasive surgery, and other causes. The company also provides devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity, and other causes. In addition, it offers continence and critical care products, including intermittent urinary catheters; and products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other urological disorders, as well as devices and products used in intensive care units and hospital settings. Further, the company provides advanced systems for managing acute fecal incontinence, as well as for monitoring urine production output and intra-abdominal pressure; and various disposable medical devices, such as wound drainage systems, urine collection bags and catheters, airway management and oxygen/aerosol therapy devices, suction handles and tubes, gastroenterology tubes, and securement devices. Additionally, it offers disposable infusion sets to manufacturers of insulin pumps for diabetes, as well as similar pumps that are used in continuous infusion treatments for other conditions; and various products to hospital and home healthcare markets. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. The company was founded in 1978 and is headquartered in Reading, the United Kingdom.

CNVVY Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CNVVY
Fax
N/A
Employees
10,142
Year Founded
N/A

Company Calendar

Ex-Dividend for 6/3 Dividend
3/31/2022
Dividend Payable
6/03/2022
Today
6/29/2022

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A














ConvaTec Group Frequently Asked Questions

Should I buy or sell ConvaTec Group stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ConvaTec Group in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ConvaTec Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CNVVY, but not buy additional shares or sell existing shares.
View analyst ratings for ConvaTec Group
or view top-rated stocks.

How has ConvaTec Group's stock performed in 2022?

ConvaTec Group's stock was trading at $9.95 at the beginning of 2022. Since then, CNVVY stock has increased by 12.6% and is now trading at $11.20.
View the best growth stocks for 2022 here
.

How often does ConvaTec Group pay dividends? What is the dividend yield for ConvaTec Group?

ConvaTec Group declared a dividend on Thursday, March 31st. Stockholders of record on Friday, April 1st will be paid a dividend of $0.1325 per share on Friday, June 3rd. This represents a yield of 1.6%. The ex-dividend date is Thursday, March 31st.
View ConvaTec Group's dividend history
.

Who are ConvaTec Group's key executives?

ConvaTec Group's management team includes the following people:
  • Mr. Karim Bitar, CEO & Director (Age 57, Pay $4.26M)
  • Mr. Frank M. Schulkes, Exec. Officer (Age 60, Pay $1.32M)
  • Mr. Jonathan P. Mason, Group CFO & Director (Age 58)
  • Mr. Donal Balfe, Exec. VP and Chief of Quality & Operations
  • Dr. Divakar Ramakrishnan Ph.D., Exec. VP & Chief Technology Officer
  • Mr. Mark Reynolds, Director of Investor Relations
  • Ms. Kate Postans, VP of Investor Relations & Corp. Communications
  • Ms. Natalia Kozmina, Exec. VP & Chief HR Officer
  • Mr. Christian Hoengaard, Sr. VP & GM - USA
  • Ms. Kjersti Grimsrud Biotechnology, M.Sc., Pres & COO of Infusion Care (Age 61)

What is ConvaTec Group's stock symbol?

ConvaTec Group trades on the OTCMKTS under the ticker symbol "CNVVY."

How do I buy shares of ConvaTec Group?

Shares of CNVVY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ConvaTec Group's stock price today?

One share of CNVVY stock can currently be purchased for approximately $11.20.

How many employees does ConvaTec Group have?

ConvaTec Group employs 10,142 workers across the globe.

How can I contact ConvaTec Group?

ConvaTec Group's mailing address is 23 Forbury Road, Reading, Berkshire RG1 3JH. The official website for ConvaTec Group is www.convatecgroup.com. The company can be reached via phone at 441189528100.

This page (OTCMKTS:CNVVY) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.